DCPrime's Seed VC Round

DCPrime raised a round of funding on September 20, 2010. Investors include Thuja Capital Management.

DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology. This platform combines antigen carrier properties with the immune-stimulatory pr…

Articles about DCPrime's Seed VC Round: